Genmab AS (GNMSF): Genmab Announces Phase II Study of Darat...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 09/16/2019 8:43:50 AM

Monday, September 16, 2019 8:43:50 AM

Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas

[GlobeNewswire] - Company Announcement

read full: http://finance.yahoo.com/news/genmab-announces-phase-ii-study-063632870.html

Keep Last Read

Next 10 Prev Next

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/20/2024 02:54:13 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/18/2024 07:46:55 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 02:01:54 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 04:46:10 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2024 06:46:36 PM

InvestorsHub NewsWire

FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM

Only $200 per official company press release!